Sterling Capital Management’s Core Laboratories CLB Stock Holding History

Sterling Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9K	Sell	939 -617	-40%	-$8.81K	﹤0.01%	2172
2026 Q1	$26.1K	Sell	1,556 -1,152	-43%	-$20.6K	﹤0.01%	1900
2025 Q4	$43.4K	Sell	2,708 -533	-16%	-$7.93K	﹤0.01%	1849
2025 Q3	$40.1K	Buy	3,241 +1,973	+156%	+$23.1K	﹤0.01%	1839
2025 Q2	$14.6K	Buy	1,268 +1,220	+2,542%	+$14.5K	﹤0.01%	1915
2025 Q1	$720	Hold	48	–	–	﹤0.01%	2902
2024 Q4	$831	Hold	48	–	–	﹤0.01%	2980
2024 Q3	$889	Buy	+48	New	+$964	﹤0.01%	2596
2019 Q3	$37.3M	Buy	+800,067	New	+$37.2M	0.35%	95
2016 Q1	–	Sell	-2,772	Closed	-$301K	–	922
2015 Q4	$301K	Buy	+2,772	New	+$317K	﹤0.01%	868
2015 Q1	–	Sell	-3,016	Closed	-$363K	–	889
2014 Q4	$363K	Buy	3,016 +665	+28%	+$87.4K	﹤0.01%	818
2014 Q3	$344K	Sell	2,351 -1,299	-36%	-$201K	﹤0.01%	799
2014 Q2	$610K	Sell	3,650 -348	-9%	-$61.9K	0.01%	688
2014 Q1	$793K	Sell	3,998 -4,629	-54%	-$874K	0.01%	659
2013 Q4	$1.65M	Buy	+8,627	New	+$1.61M	0.02%	285

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sterling Capital Management's CLB Position: Q2 2026 in Review

Sterling Capital Management reduced its Core Laboratories (CLB) stake by 40% in Q2 2026, selling an estimated $8.81K and leaving 939 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Sterling Capital Management first reported a position in CLB in Q4 2013 and has held it in 15 quarters since. The position peaked at $37.3M in Q3 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Sterling Capital Management held 939 shares of Core Laboratories worth $10.9K as of Q2 2026.
Sterling Capital Management sold 617 Core Laboratories shares in Q2 2026, an estimated $8.81K.
Core Laboratories made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2172 holding.
Sterling Capital Management first reported a position in Core Laboratories in Q4 2013 and has held it in 15 quarters since.
Sterling Capital Management's Core Laboratories position peaked at $37.3M in Q3 2019.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.